Evidence map›Paper›PMID 40903212›Full record

ArticleCell proliferation2025

Targeting ARPC1B

Yang Wu, Jianpeng Zhang, Weixiong Zhu, Xinrui Zhu, Yi Liu, Xin Wang, Tianyu Zhao, Chun Zhang, Zili Zhang, Wenjie Shi and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell proliferation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Integrative multi-omics reveals the POSTNFrontiers in immunology · 2026
    Article
  5. Targeting ARPC1BCell proliferation · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yang WuPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0002-0906-9667
Jianpeng ZhangDepartment of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0009-0009-7533-3751
Weixiong ZhuThe Second Clinical Medical College, Lanzhou University, Lanzhou, China.ORCID https://orcid.org/0009-0009-7247-8111
Xinrui ZhuDepartment of Hepatobiliary and Pancreatic Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Yi LiuDepartment of Oncology, The Second Hospital of Dalian Medical University, Dalian, China.
Xin WangDepartment of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Tianyu ZhaoInstitute of Social Medicine and Epidemiology, Medical University of Graz, Graz, Austria.
Chun ZhangDepartment of Gastroenterology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Zili ZhangState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, China.
Wenjie ShiMolecular and Experimental Surgery, Clinic for General-, Visceral-, Vascular- and Transplantation Surgery, Medical Faculty and University Hospital Magdeburg, Otto-von-Guericke University, Magdeburg, Germany.ORCID https://orcid.org/0009-0001-7345-579X
Run ShiDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhaokai ZhouDepartment of Urology, The Second Xiangya Hospital of Central South University, Changsha, China.ORCID https://orcid.org/0000-0001-6628-3750
Shaohui XuInstitute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, China.

Funding

Jiangsu Funding Program for Excellent Postdoctoral Talent 2024ZB683Jiangsu Province "Double-Creation Doctorate" Talent Program JSSCBS20220472Jiangsu Province "Double-Creation Doctorate" Talent Program JSSCBS20221832Jiangsu Provincial Health Commission Medical Research Project 215Jiangsu Provincial Hospital of Traditional Chinese Medicine Excellent Doctoral Cultivation Program 2023QB0124National Natural Science Foundation of China 82304902Postdoctoral Fellowship Program of CPSF GZC20241189Science and Technology Innovation Project for Nanjing Overseas Chinese B42The Incubation Program of National Natural Science Foundation of Jiangsu Provincial People's Hospital 39
6 · The paper itself

Abstract

ARPC1B

Indexed as

DeoxycytidineNeoplastic Stem CellsPancreatic NeoplasmsAnimalsAntimetabolites, AntineoplasticCell Line, TumorDrug Resistance, NeoplasmGemcitabineHumansMiceMice, NudeMolecular Docking SimulationXenograft Model Antitumor AssaysAntimetabolites, AntineoplasticDeoxycytidineGemcitabine

Identifiers

PMID40903212
PMCPMC12686117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.